NEW YORK (AP) -- Mylan, now in the crosshairs over severe price hikes for its EpiPen, says it will expand programs that lower out-of-pocket costs by as much as half....
Associated Press: Health
Thu, 08/25/2016 - 4:40am
NEW YORK (AP) -- Mylan, now in the crosshairs over severe price hikes for its EpiPen, says it will expand programs that lower out-of-pocket costs by as much as half....